Credit Suisse Ag Axonics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Axonics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 99,555 shares of AXNX stock, worth $7.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

99,555

Previous 984,060 89.88%

Holding current value

$7.07 Million

Previous $61.2 Million 88.79%

% of portfolio

0.01%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$56.67 - $69.36 $50.1 Million - $61.3 Million	-884,505 Reduced 89.88%	99,555 $6.87 Million
Q4 2023 Feb 08, 2024	SELL	$49.38 - $63.75 $5.05 Million - $6.52 Million	-102,312 Reduced 9.42%	984,060 $61.2 Million
Q3 2023 Nov 13, 2023	SELL	$48.64 - $62.51 $12.8 Million - $16.5 Million	-263,329 Reduced 19.51%	1,086,372 $61 Million
Q2 2023 Aug 11, 2023	BUY	$47.99 - $60.21 $18.3 Million - $23 Million	381,471 Added 39.4%	1,349,701 $68.1 Million
Q1 2023 May 10, 2023	BUY	$52.6 - $67.34 $276,044 - $353,400	5,248 Added 0.54%	968,230 $52.8 Million
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $9.53 Million - $12.3 Million	-160,044 Reduced 14.25%	962,982 $60.2 Million
Q3 2022 Nov 10, 2022	SELL	$57.96 - $78.12 $28.5 Million - $38.4 Million	-490,947 Reduced 30.42%	1,123,026 $79.1 Million
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $11.5 Million - $18.7 Million	-290,663 Reduced 15.26%	1,613,973 $91.5 Million
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $16.1 Million - $23.1 Million	-368,562 Reduced 16.21%	1,904,636 $119 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $3.22 Million - $4.73 Million	64,421 Added 2.92%	2,273,198 $127 Million
Q3 2021 Nov 12, 2021	SELL	$59.21 - $78.66 $23.5 Million - $31.3 Million	-397,586 Reduced 15.25%	2,208,777 $144 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $553,984 - $721,182	10,780 Added 0.42%	2,606,363 $165 Million
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $3.17 Million - $3.87 Million	64,602 Added 2.55%	2,595,583 $155 Million
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $24 Million - $29.3 Million	568,745 Added 28.98%	2,530,981 $126 Million
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $15.8 Million - $22.9 Million	448,281 Added 29.61%	1,962,236 $100 Million
Q2 2020 Aug 12, 2020	BUY	$22.91 - $39.83 $34.5 Million - $59.9 Million	1,505,074 Added 16947.12%	1,513,955 $53.2 Million
Q1 2020 May 13, 2020	SELL	$16.44 - $37.73 $103,095 - $236,604	-6,271 Reduced 41.39%	8,881 $226,000
Q4 2019 Feb 12, 2020	BUY	$19.57 - $28.96 $296,524 - $438,801	15,152 New	15,152 $420,000
Q3 2019 Nov 12, 2019	SELL	$26.92 - $42.41 $146,714 - $231,134	-5,450 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $101,043 - $223,286	5,450 New	5,450 $223,000

Others Institutions Holding AXNX

# of Institutions

235

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account